BHEL Q4 results 2026: Profit jumps nearly threefold to ₹1,290 crore; declares a final dividend of ₹1.40 for FY26 LiveMint · Markets 17m ago
UCB To Acquire Candid Therapeutics For Up To $2.2 Bln To Boost Immunology Pipeline NASDAQ · Markets 48m ago
Endeavour Group Q3 Total Sales Up, Sees Addl. Fuel Charges, A$100 Mln Cost Savings; Stock Down NASDAQ · Markets 1h ago
The nuclear option: Atomic energy could offer Europe hope, say analysts — but it won't be easy CNBC · Markets 1h ago
Denmark faces data center reckoning as power grid overwhelmed by surging demand CNBC · Markets 1h ago